Hyperthermia as an immunotherapy strategy for cancer
/in Hyperthermia, International Publications /von 2009-06-01 / Curr Opin Investig Drugs 2009 Jun;10(6):550-8[Dendritic cell-based immunotherapy for multiple myeloma — review]
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2009-06-01 / Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 Jun;17(3):821-5Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2009-06-01 / Int. J. Oncol. 2009 Jun;34(6):1701-15Cellular immunotherapy for ovarian cancer
/in Dendritic Cells, International Publications, Ovarian Cancer /von 2009-06-01 / Expert Opin Biol Ther 2009 Jun;9(6):677-88Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma
/in Dendritic Cells, International Publications, Thyroid Cancer /von 2009-06-01 / Oncol. Rep. 2009 Jun;21(6):1585-92Dendritic cell-based cancer immunotherapies
/in Dendritic Cells, International Publications /von 2009-05-29 / Arch. Immunol. Ther. Exp. (Warsz.) 2009 May-Jun;57(3):189-98Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2009-05-27 / Cell. Immunol. 2009;259(1):13-20On immunotherapies and cancer vaccination protocols: a mathematical modelling approach
/in Dendritic Cells, International Publications /von 2009-05-14 / J. Theor. Biol. 2009 Aug;259(4):820-7Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2009-05-14 / Cancer Sci. 2009 Aug;100(8):1502-9IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de